Press Releases

08 Feb 2023

Press Release

US FDA 510(k) Clearance and CLIA-waiver for the fast and innovative BIOFIRE® SPOTFIRE® System

bioMérieux receives US FDA 510(k) Clearance and CLIA-waiver for the fast and innovative BIOFIRE® SPOTFIRE® System and its BIOFIRE® SPOTFIRE® Respiratory (R) Panel and will be submitting the BIOFIRE® SPOTFIRE® Respiratory (R) Panel Mini for 510(k) clearance.

01 Feb 2023

Press Release

MAESTRIA™, a new generation microbiology middleware developed by bioMérieux

bioMérieux, a world leader in the field of in vitro diagnostics, launches MAESTRIA™. This new generation middleware for the microbiology laboratory aims at providing a central software tool for the workflow management of all routine activities.

20 Dec 2022

Business & Solutions

CE-marking of VIDAS® KUBE™, the next generation system in the VIDAS® immunoassay portfolio

VIDAS® KUBE™ is the next generation automated immunoassay system for the renowned VIDAS® range. It will benefit clinical labs and food industries by providing results to help speed up patient care and protect consumers.

15 Dec 2022

Financial Information

2022 increased outlook and 2023 preview guidance

bioMérieux, a world leader in the field of in vitro diagnostics, today released its adjusted outlook for full-year 2022 and a preview of 2023 guidance.

16 Nov 2022

Antimicrobial Resistance

Survey bioMérieux OpinionWay - Antimicrobial Resistance and diagnostic tests

To mark World Antimicrobial Awareness Week organized by the WHO from November 18-24, bioMérieux presents the results of a bioMérieux/OpinionWay survey on the general public's knowledge of antimicrobial resistance and the use of diagnostic tests in France.

26 Oct 2022

Financial Information